Jennifer L. McNeer to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Jennifer L. McNeer has written about Precursor B-Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
2.804
-
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. Blood Adv. 2026 06 23; 10(12):4184-4192.
Score: 0.896
-
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group. J Clin Oncol. 2019 04 01; 37(10):780-789.
Score: 0.538
-
Pediatric Acute Lymphoblastic Leukemia: From Diagnosis to Prognosis. Pediatr Ann. 2015 Jul; 44(7):e168-74.
Score: 0.419
-
Blinatumomab Utilization in Pediatric B-Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West. Pediatr Blood Cancer. 2026 Jul; 73(7):e70383.
Score: 0.222
-
The challenge of deintensifying chemotherapy for children and adolescents with B-ALL in the immunotherapy era. Hematology Am Soc Hematol Educ Program. 2025 12 05; 2025(1):229-235.
Score: 0.216
-
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891.
Score: 0.201
-
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892.
Score: 0.131
-
RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2015 Apr; 56(4):1145-7.
Score: 0.099
-
Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol. 2012 Feb; 29(1):2-11.
Score: 0.083